Brief: PLx Pharma Says Received Non-Compliance Notice From Nasdaq
Oct 7 (Reuters) - PLx Pharma Inc PLXP.O :
* PLX PHARMA INC - ON OCTOBER 3, CO RECEIVED NOTICE FROM
NASDAQ
THAT CO IS NOT BEEN IN COMPLIANCE WITH THE MINIMUM BID PRICE
REQUIREMENT
Further company coverage: PLXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PLx Pharma Winddown
See all newsAustralia's Pilbara Minerals jumps on Pilgangoora lithium resource upgrade
Brief: Plx Pharma Winddown Terminated Employment Of Natasha Giordano, President And CEO, And Rita O'connor, CFO
Brief: PLx Pharma Inc. Enters Into A Stalking Horse Asset Purchase Agreement To Sell Vazalore And Substantially All Of Its Assets
U.S. STOCKS ON THE MOVE-HeartCore, Freight Technologies, MongoDB
Brief: Plx Pharma Inc. Receives Nasdaq Delisting Notice